World 800m champion Marco Arop has explained why he feels he has the capabilities to lower David Rudha’s 13-year world record, shedding light on the possible event to do it from.
Citius Pharmaceuticals shares are trading lower by 15% during Wednesday's session. The company announced a $3 million ...
Citius Pharmaceuticals (CTXR) announced that it has entered into definitive agreements for the purchase of an aggregate of 743,496 shares of ...
Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to the ...
Citius Pharmaceuticals (CTXR) and its oncology-focused subsidiary, Citius Oncology (CTOR), announced progress in preparations for the ...
Nov. 20, 2024 — Wings may be the obvious choice when studying the connection between dinosaurs and birds, but a pair of paleontologists prefer drumsticks. That part of the leg, they say, is ...
I-Mab halts CD73 program to focus on givastomig, General Proximity emerges with $16M for undruggable proteins, PBS Biotech raises $17M, Citius explores sale ...
After nabbing an FDA approval last summer for its T-cell lymphoma treatment Lymphir, Citius Oncology is eyeing strategic ...
2d
Citius Oncology, Inc. ("Citius Oncology" or "the Company") (Nasdaq: CTOR), a majority-owned subsidiary of Citius ...
Nandita Vijayasimha, Bengaluru Thursday, January 2, 2025, 08:00 Hrs [IST] ...
Olympic champion Masai Russell recently shared her 'vision board' achievements as she reflected on her 2024 season.
Denileukin diftitox is under clinical development by Citius Oncology and currently in Pre-Registration for Mycosis Fungoides.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback